ARRAY BIOPHARMA
Array BioPharma is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company partnered drugs are binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology), and tucatinib (partnered with Cascadian Therapeutics). The company is committed to providing therapies to patients. Array BioPharma was founded on 1998 and is headquartered in Boulder, Colorado.
ARRAY BIOPHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
1998-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.arraybiopharma.com
Total Employee:
51+
Status:
Closed
Contact:
303.381.6600
Email Addresses:
[email protected]
Total Funding:
121.4 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Google Maps Microsoft Azure DNS Google Maps API Microsoft IIS 7
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Post-IPO Equity - Array BioPharma
Deerfield
Deerfield investment in Post-IPO Debt - Array BioPharma
Deerfield
Deerfield investment in Post-IPO Debt - Array BioPharma
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Venture Round - Array BioPharma
Official Site Inspections
http://www.arraybiopharma.com
- Host name: 147.154.27.36
- IP address: 147.154.27.36
- Location: Seattle United States
- Latitude: 47.6109
- Longitude: -122.3303
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98101
More informations about "Array BioPharma" on Search Engine
Array BioPharma - Wikipedia
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is a subsidiary of Pfizer.See details»
Pfizer Completes Acquisition of Array Biopharma
Jul 30, 2019 Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, …See details»
Array BioPharma - Crunchbase Company Profile & Funding
Array BioPharma is a biopharmaceutical company focused on the development and commercialization of targeted small molecule drugs. Acquired by. Pfizer. Boulder, …See details»
Array BioPharma Inc. | LinkedIn
Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat …See details»
Pfizer to acquire US company Array BioPharma for $11.4bn
Jun 18, 2019 Array BioPharma develops and commercialises targeted small molecule medicines for the treatment of cancer and other diseases. The company has a broad …See details»
Array BioPharma | Discovery Platform
Array BioPharma | Discovery Platform. Research platforms: target- and phenotype-based drug discovery. Array’s world-class research proficiencies are rooted in a 20-year legacy …See details»
Pfizer completes acquisition of Array Biopharma
Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development …See details»
Array BioPharma | Areas of Focus
Array BioPharma's areas of focus include the development of targeted therapies to inhibit molecular pathways involved in disease progression.See details»
Strengthening Pfizer’s R&D Engine and Oncology …
The acquisition of Colorado-based biotech Array BioPharma in July 2019 sets the stage for Pfizer to create a potentially industry-leading franchise for colorectal cancer alongside the company’s leadership in breast and …See details»
Array's ‘extremely compelling’ new colon cancer data spark …
May 22, 2019 The news that Array BioPharma’s clinical trial of its triplet therapy for colon cancer extended lives in a trial of patients with the BRAF mutation sent the company’s …See details»
Array BioPharma | Patients & Caregivers
Array BioPharma is dedicated to improving the lives of those living with cancer. And this is just the beginning. We are a biopharmaceutical company focused on the discovery, …See details»
Array BioPharma Announces Restructuring | Fierce Pharma
Jun 13, 2011 6:20pm. Aligning Resources with Clinical Programs. BOULDER, Colo.-- ( BUSINESS WIRE )-- Array BioPharma Inc. (NASDAQ: ARRY) today announced a …See details»
Foundation Medicine Announces Collaboration with Array …
CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine …See details»
Pfizer acquires Array BioPharma - 2019-06-17 - Crunchbase
Jun 17, 2019 Overview. Acquired Organization: Array BioPharma Array BioPharma is a biopharmaceutical company focused on the development and commercialization of …See details»
Array BioPharma - Funding, Financials, Valuation & Investors
Funding. Array BioPharma has raised a total of. $412.1M. in funding over 6 rounds. Their latest funding was raised on Sep 14, 2017 from a Post-IPO Equity round. Array …See details»
Pfizer Completes Acquisition of Array Biopharma - Business Wire
Jul 30, 2019 NEW YORK-- ( BUSINESS WIRE )--Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing …See details»
Organization | Array BioPharma
Organization Overview. First Clinical Trial. 2004 NCT00085787. First Marketed Drug. 2018 binimetinib . First NDA Approval ... Array BioPharma | Array BioPharma, Inc | Array …See details»
Rentschler Biopharma Appoints Patrick Meyer as Global Head
6 hours ago Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers …See details»
Organization | Array BioPharma - CDEK
Organization Overview. First Clinical Trial. 2004 NCT00085787. First Marketed Drug. 2018 ... Array BioPharma | Array BioPharma, Inc | Array BioPharma, Inc. | ARRAY …See details»
Chief Operating Officer @ Array BioPharma - Crunchbase
Overview. CB Rank (Person) 479,512. Primary Job Title Chief Operating Officer. Primary Organization. Array BioPharma. Location Boulder, Colorado, United States. Regions …See details»